Fensterle et al. showed that mice immunized with an S. Typhimurium strain release prostate-specific antigen (PSA) via the HlyA (T1SS) system, activate CD8+ T lymphocyte-mediated immune response, and ultimately inhibit tumor development [51,52]. This evidence concerns the gene KLK3 and neoplasm.